Page
%P
-
Chapter and Conference Paper
Treatment of Post-Transplant Lymphomas with Anti-B-Cell Monoclonal Antibodies
The treatment of post-transplant lymphomas still needs major improvements in order to put the patient in remission and to retain graft function. Chemotherapy is far too toxic in these patients. A more specific...
-
Chapter and Conference Paper
Interleukin-2 Therapy: Report on 129 Patients and Three Different Schedules
Approximately one-half of patients with renal carcinoma develop metastases, and these have a median survival of 8 months [6, 11, 12]. Metastatic renal cancer has been considered for the past 20 years as a tumo...